Early research (Phase 1)Study completedNCT01635712What this trial is testingSafety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological MalignanciesWho this might be right forCancer Esanex Inc. 10
Very early researchLooking for participantsNCT07131254What this trial is testingA Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological TumorsWho this might be right forHematological Malignancy (Leukemia- Lymphoma) Grit Biotechnology 34
Early research (Phase 1)UnknownNCT00710697What this trial is testingCardiac Safety Assessment Study of Picoplatin in Solid TumorsWho this might be right forSolid Tumors Poniard Pharmaceuticals 40
Testing effectiveness (Phase 2)UnknownNCT02328352What this trial is testing"BP as a New Device for Surgery and Solid Cancer and Hematopoietic System Tumors Treatment. Effects of BP Implantation"Who this might be right forHernia of Abdominal WallIncisional Hernia University of Roma La Sapienza 30
Early research (Phase 1)Looking for participantsNCT03829540What this trial is testingCD4CAR for CD4+ Leukemia and LymphomaWho this might be right forT-cell LymphomaT-cell Leukemia Huda Salman 20
Testing effectiveness (Phase 2)Study completedNCT00317785What this trial is testingTotal-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Not applicableWithdrawnNCT02298816What this trial is testingB-Cell Hematologic Malignancy Vaccination RegistryWho this might be right forMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia+4 more Wake Forest University Health Sciences
Not applicableStudy completedNCT00715247What this trial is testingPolycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET GenesWho this might be right forPolycythemia VeraEssential ThrombocythemiaMyelofibrosis University of Utah 726
Testing effectiveness (Phase 2)Study completedNCT00379587What this trial is testingRituximab for Prevention of Chronic GVHDWho this might be right forHematological Malignancies Dana-Farber Cancer Institute 65
Early research (Phase 1)Study completedNCT00788684What this trial is testingSafety Study of ABT-263 in Combination With Rituximab in Lymphoid CancersWho this might be right forCD20-Positive Lymphoid MalignanciesChronic Lymphoid LeukemiaHematological Malignancies+1 more AbbVie 29
Not applicableStudy completedNCT00195533What this trial is testingStudy Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic PatientsWho this might be right forHematological MalignancyLeukemiaMyelodysplasia+3 more Wyeth is now a wholly owned subsidiary of Pfizer 801
Testing effectiveness (Phase 2)WithdrawnNCT07071909What this trial is testingImmune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T CellsWho this might be right forMalignancyCancerHematological Malignancies+4 more UNC Lineberger Comprehensive Cancer Center
Not applicableLooking for participantsNCT07019766What this trial is testingNational Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic LeukemiaWho this might be right forT-LGL LeukemiaNK-LGL Leukemia Institute of Hematology & Blood Diseases Hospital, China 9,999
Early research (Phase 1)Looking for participantsNCT06904066What this trial is testingAutologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesWho this might be right forMalignancy, HematologicNeoplasms, HematologicNeoplasms, Hematopoietic+8 more National Cancer Institute (NCI) 86
Not applicableUnknownNCT06258629What this trial is testingPrognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and MortalityWho this might be right forHematological Malignancies Sohag University 40
Early research (Phase 1)Ended earlyNCT02679131What this trial is testingTo Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.Who this might be right forRelapsed/Refractory Solid Tumors/Hematological Malignancies Acrotech Biopharma Inc. 18
Not applicableStudy completedNCT02452099What this trial is testingImpact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.Who this might be right forMultiple MyelomaLymphomasLeukemias Maria Sklodowska-Curie National Research Institute of Oncology 150
Not applicableLooking for participantsNCT07051525What this trial is testingEarly Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and FeverWho this might be right forLeukemiaCART TherapyTransplantation, Stem Cell+1 more Peter MacCallum Cancer Centre, Australia 214
Early research (Phase 1)Ended earlyNCT04764474What this trial is testingHMPL-306 in Advanced Hematological Malignancies With mIDHWho this might be right forIsocitrate Dehydrogenase Gene Mutation Hutchmed 46